# Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)

> **NCT02282293** · PHASE3 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 200 (actual)

## Conditions studied

- Malaria
- Human Immunodeficiency Virus

## Interventions

- **DRUG:** Monthly dihydroartemisinin-piperaquine (DP) + daily trimethoprim/sulfamethoxazole (TS)
- **DRUG:** Monthly placebo + daily trimethoprim/sulfamethoxazole (TS)

## Key facts

- **NCT ID:** NCT02282293
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-09
- **Primary completion:** 2016-05-26
- **Final completion:** 2016-05-26
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2019-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02282293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02282293, "Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02282293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*